GB Meka
Stocks to watch

ALT

Compare

ALTIMMUNE INC · Healthcare

$2.86
▼ 3.7%Close 2026-09-30

Live intraday price

Compare with our price levels

T23.26
T13.13
E12.74
E32.37
SL2.24

Close 2026-09-30: $2.86 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 4.4% · 1 whale recently bought

1 month
▼ 8.0%
3 months
▼ 9.2%
1 year
▼ 24.5%
Analyst target
$17.11 +498.3%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$2.74 -4.4%
E2$2.56 -10.3%
E3$2.37 -17.2%
Targets
T1$3.13 9.4%
T2$3.26 13.9%
T3$3.40 18.9%
Stop-loss
SL$2.24 -21.7%
Whale cost ~$2.93 2.4%

Risk : reward 1 : 2.2Moves ~$0.13 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●1 whale bought or added last quarter
  • ●Average analyst price target 17.11 (upside +498%, 9 analysts)
  • ●Most analysts rate it Strong Buy
! Risks (2)
  • ●Long-term downtrend (below a falling MA200)
  • ●Lagged the market (S&P 500) by -25% over 6 months

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Buy

Durso Jerome Benedict · CEO · Director

2026-08-13 · 15,000 shares @ $2.95

$44,250

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-12In line +4%

Actual EPS -$0.12 · est. -$0.12 · Before open

▼ 2.3%

Day 1

+12.3%

Next 20 days

2026-05-13Beat +28%

Actual EPS -$0.18 · est. -$0.25 · Before open

▼ 1.9%

Day 1

-14.2%

Next 20 days

2026-03-05Miss -11%

Actual EPS -$0.27 · est. -$0.24 · Before open

▼ 17.9%

Day 1

-4.7%

Next 20 days

2025-11-06Beat +21%

Actual EPS -$0.21 · est. -$0.27 · Before open

▲ 5.1%

Day 1

+33.0%

Next 20 days

2025-08-12Beat +16%

Actual EPS -$0.27 · est. -$0.32 · Before open

▲ 7.1%

Day 1

+1.4%

Next 20 days

2025-05-13Beat +24%

Actual EPS -$0.26 · est. -$0.34 · Before open

▼ 4.2%

Day 1

+13.5%

Next 20 days

2025-02-27In line +2%

Actual EPS -$0.33 · est. -$0.34 · Before open

▲ 8.1%

Day 1

-13.2%

Next 20 days

2024-11-12Beat +10%

Actual EPS -$0.32 · est. -$0.36 · Before open

▲ 29.1%

Day 1

-7.9%

Next 20 days

Listen to the earnings call or read the full report on ALT's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$581M
Next earnings2026-11-05
P/E (price to earnings)-
Forward P/E (on expected earnings)-4.5
Revenue growth (YoY)-
Earnings growth (YoY)-
Net profit margin0.0%
ROE-28.9%
Debt to equity (D/E)8%
Dividend yield-
Analyst targets (high / low)$28.00 / $11.00
Number of analysts9
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Downtrend ↘
RSI36
MA50 / MA200$3.09 / $3.49
Distance from MA200-17.9%
MACDNegative
1-year high / low$6.44 / $2.56
vs. S&P 500 (6 months)-25.0%
Volume vs. average1.27×